Somatostatin Analog [EPC]

6873 reported adverse events

Drugs of this class: OCTREOTIDE PASIREOTIDE

These side effects are most commonly reported by patients taking drugs of the Somatostatin Analog [EPC] class:

# Side effect Count
0 OFF LABEL USE 856
1 DRUG INEFFECTIVE 826
2 DIARRHOEA 663
3 NAUSEA 532
4 FATIGUE 450
5 DEATH 422
6 VOMITING 302
7 ABDOMINAL PAIN 284
8 MALIGNANT NEOPLASM PROGRESSION 268
9 HEADACHE 250
See all common reactions for Somatostatin Analog [EPC]

Drugs of the Somatostatin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR V ANTIBODY 19 0.6786
1 ELECTROCARDIOGRAM T WAVE ALTERNANS 16 0.3721
2 CARCINOID CRISIS 60 0.2655
3 CARCINOID HEART DISEASE 19 0.2088
4 CARCINOID SYNDROME 36 0.0994
5 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 19 0.0795
6 PANCREATIC NEUROENDOCRINE TUMOUR 45 0.0702
7 BLOOD CHROMOGRANIN A INCREASED 21 0.0458
8 BLOOD GROWTH HORMONE INCREASED 25 0.0448
9 CORTISOL INCREASED 27 0.0432
See all enriched reactions for Somatostatin Analog [EPC]